Phototoxic effects of 635-nm light on canine transitional cell carcinoma cells incubated with 5-aminolevulinic acid

American Journal of Veterinary Research

Volumn 64, Issue 2, 2003, Pages 131-136

  Ridgway, Tisha D ^a,b   Lucroy, Michael D ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DIODE LASER; DOG; DOSE RESPONSE; DRUG EFFICACY; ENERGY RESOURCE; IN VITRO STUDY; INCUBATION TIME; LIGHT EXPOSURE; LIGHT INTENSITY; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; POWER SPECTRUM; TRANSITIONAL CELL CARCINOMA;

AMINOLEVULINIC ACID; ANIMALS; CARCINOMA, TRANSITIONAL CELL; CELL SURVIVAL; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; LASERS; LIGHT; PHOTOCHEMOTHERAPY; PROTOPORPHYRINS; TIME FACTORS; TUMOR CELLS, CULTURED;

ANIMALIA; CANIS FAMILIARIS;

EID: 0037317238     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2003.64.131     Document Type: Article

References (40)

1. Norris AM, Laing EJ, Valli VE, et al. Canine bladder and urethral tumors: a retrospective study of 115 cases (1980-1985). J Vet Intern Med 1992;6:145-153.
2. Helfand SC, Hamilton TA, Hungerford LL, et al. Comparison of three treatments for transitional cell carcinoma of the bladder in the dog. J Am Anim Hosp Assoc 1994;30:270-275.
3. Walker M, Breider M. Intraoperative radiotherapy of canine bladder cancer. Vet Radiol 1987;28:200-204.
4. Chun R, Knapp DW, Widmer WR, et al. Cisplatin treatment of transitional cell carcinoma of the urinary bladder in dogs: 18 cases (1983-1993). J Am Vet Med Assoc 1996;209:1588-1591.
5. Knapp DW, Richardson RC, Chan TC, et al. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 1994;8:273-278.
6. Knapp DW, Glickman NW, Widmer WR, et al. Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer. Cancer Chemother Pharmacol 2000;46:221-226.
7. Knapp DW, Glickman NW, DeNicola DB, et al. Naturally-occurring canine transitional cell carcinoma of the urinary bladder. A relevant model of human invasive bladder cancer. Urol Oncol 2000;5:47-59.
8. Kriegmair M, Baumgartner R, Lumper W, et al. Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer. Br J Urol 1996;77:667-671.
9. Nseyo UO, Merrill DC, Lundahl SL. Green light photodynamic therapy in the human bladder. Clin Laser Mon 1993;11:247-250.
10. Nseyo UO, DeHaven J, Dougherty TJ, et al. Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: a long-term experience. J Clin Laser Med Surg 1998;16:61-68.
11. Jichlinski P, Leisinger HJ. Photodynamic therapy in superficial bladder cancer: past, present and future. Urol Res 2001;29:396-405.
12. Lucroy MD, Magne ML, Peavy GM, et al. Photodynamic therapy in veterinary medicine: current status and implications for applications in human disease. J Clin Laser Med Surg 1996;14:305-310.
13. Lucroy MD, Edwards BF, Madewell BR. Veterinary photodynamic therapy. J Am Vet Med Assoc 2000;216:1745-1751.
14. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol 1992;55:145-157.
15. Oleinick NL, Evans HH. The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat Res 1998;150:S146-S156.
16. Peavy GM, Krasieva TB, Tromberg BJ, et al. Variation in the distribution of a phthalocyanine photosensitizer in naturally occurring tumors of animals. J Photochem Photobiol B 1995;27:271-275.
17. Nseyo UO, Whalen RK, Lundahl SL. Canine bladder response to red and green light whole bladder photodynamic therapy. Urology 1993;41:392-396.
18. Peng Q, Warloe T, Berg K, et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997;79:2282-2308.
19. Noodt BB, Berg K, Stokke T, et al. Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX. Br J Cancer 1996;74:22-29.
20. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1990;6:143-148.
21. Hua Z, Gibson SL, Foster TH, et al. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. Cancer Res 1995;55:1723-1731.
22. Bedwell J, MacRobert AJ, Phillips D, et al. Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. Br J Cancer 1992;65:818-824.
23. Marcus SL, Sobel RS, Golub AL, et al. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): current clinical and development status. J Clin Laser Med Surg 1996;14:59-66.
24. Lucroy MD, Edwards BF, Peavy GM, et al. Preclinical study in cats of the pro-photosensitizer 5-aminolevulinic acid. Am J Vet Res 1999;60:1364-1370.
25. Stell AJ, Dobson JM, Langmack K. Photodynamic therapy of feline superficial squamous cell carcinoma using topical 5-aminolaevulinic acid. J Small Anim Pract 2001;42:164-169.
26. Knapp DW, Chan TC, Kuczek T, et al. Evaluation of in vitro cytotoxicity of nonsteroidal anti-inflammatory drugs against canine tumor cells. Am J Vet Res 1995;56:801-805.
27. O'Brien J, Wilson I, Orton T, et al. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 2000;267:5421-5426.
28. Ahmed SA, Gogal RM Jr, Walsh JE. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J Immunol Methods 1994;170:211-224.
29. Datta SN, Loh CS, MacRobert AJ, et al. Quantitative studies of the kinetics of 5-aminolaevulinic acid-induced fluorescence in bladder transitional cell carcinoma. Br J Cancer 1998;78:1113-1118.
30. Gronlund-Pakkanen S, Makinen K, Talja M, et al. The importance of fluorescence distribution and kinetics of ALA-induced PpIX in the bladder in photodynamic therapy. J Photochem Photobiol B 1997;38:269-273.
31. Xiang W, Weingandt H, Liessmann F, et al. Photodynamic effects induced by aminolevulinic acid esters on human cervical carcinoma cells in culture. Photochem Photobiol 2001;74:617-623.
32. Peng Q, Berg K, Moan J, et al. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol 1997;65:235-251.
33. Loh CS, Vernon D, MacRobert AJ, et al. Endogenous perphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. J Photochem Photobiol B 1993;20:47-54.
34. Kennedy JC, Marcus SL, Pottier RH. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results. J Clin Laser Med Surg 1996;14:289-304.
35. Egger NG, Motamedi M, Pow-Sang M, et al. Accumulation of porphyrins in plasma and tissues of dogs after delta-aminolevulinic acid administration: implications for photodynamic therapy. Pharmacology 1996;52:362-370.
36. Robinson DJ, de Bruijn HS, van der Veen N, et al. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect. Photochem Photobiol 1998;67:140-149.
37. van Geel IP, Oppelaar H, Marijnssen JP, et al. Influence of fractionation and fluence rate in photodynamic therapy with Photofrin or mTHPC. Radiat Res 1996;145:602-609.
38. Riesenberg R, Fuchs C, Kriegmair M. Photodynamic effects of 5-aminolevulinic acid-induced porphyrin on human bladder carcinoma cells in vitro. Eur J Cancer 1996;32A:328-334.
39. Bachor R, Reich E, Ruck A, et al. Aminolevulinic acid for photodynamic therapy of bladder carcinoma cells. Urol Res 1996;24:285-289.
40. Datta SN, Allman R, Loh CS, et al. Photodynamic therapy of bladder cancer cell lines. Br J Urol 1997;80:421-426.